Treatment(s) now being considered-Percutaneous coronary intervention (PCI) Posts on Medivizor
Navigation Menu

Treatment(s) now being considered-Percutaneous coronary intervention (PCI) Posts on Medivizor

Is angioplasty as safe as coronary artery bypass grafting in people with left main coronary artery disease?

Posted by on Nov 9, 2017 in Coronary artery disease | 0 comments

In a nutshell This study compared the safety of percutaneous coronary intervention (PCI) with drug-eluting stents (DESs) to coronary artery bypass grafting (CABG) in patients with left main coronary artery disease (LMCAD). It determined that PCI and CABG were equally safe, mortality-wise. However, PCI was associated with more non-fatal heart attacks,...

Read More

Comparing treatment methods for non-ST elevation acute coronary syndrome

Posted by on Nov 9, 2017 in Coronary artery disease | 0 comments

In a nutshell This study aimed to compare the outcomes of coronary artery bypass grafting and percutaneous coronary intervention with drug eluting stents in patients with non-ST elevation acute coronary syndrome. This study concluded that non-ST elevation acute coronary syndrome patients treated with coronary artery bypass grafting had better...

Read More

Can percutaneous coronary intervention lead to depression and anxiety?

Posted by on Sep 10, 2017 in Coronary artery disease | 0 comments

In a nutshell This study aimed to investigate the prevalence of depression and anxiety symptoms in patients with myocardial infarction who are treated with primary percutaneous coronary intervention. This study concluded that these patients had low rates of depression and anxiety symptoms following treatment, but these symptoms may increase after a...

Read More

How long should dual antiplatelet therapy be given after a drug-eluting stent insertion?

Posted by on Sep 19, 2016 in Coronary artery disease | 0 comments

In a nutshell This paper studied how long dual antiplatelet therapy should be given for after a drug-eluting stent insertion. The authors concluded that continuing dual antiplatelet therapy beyond 12 months can be carefully considered in selected patients with low bleeding risk.  Some background A drug-eluting stent is a mesh wire structure...

Read More

5-Year outcome of a bioresorbable stent

Posted by on Jun 18, 2016 in Coronary artery disease | 0 comments

In a nutshell This paper studied the long-term outcomes from the implantation of a bioresorbable scaffold that releases everolimus in patients with coronary stenosis. The 5-year study found that the scaffold was safe for use.  Some background Coronary stenosis refers to narrowing of the blood vessels that supply blood to the heart. This is...

Read More

Do complications during percutaneous coronary intervention affect outcome ?

Posted by on Jan 17, 2016 in Coronary artery disease | 0 comments

In a nutshell The authors studied whether complications during a percutaneous coronary intervention affects outcome in patients. The authors concluded that intra-procedural thrombotic events are associated with greater mortality and other events during hospitalization, 30 days after hospitalization and in the long-term. Some background...

Read More